Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Clio Health Launches Clio Health Go App, Enabling Secure, Self-directed, Touchless, COVID-19 Screenings and Check-ins at Local Schools and Organizations


The touchless, automated GO Pass kiosk is one of several form factors available.

GO Pass facilitates consistent and easy screening. It has simply taken our COVID-19 protocol to the next level.

Today, Clio Health launched the Clio Health Go app featuring GO Pass to direct students, staff, and visitors to complete a quick, confidential COVID-19 screening and biometric analysis in order to receive an electronic entrance pass. Similar to scanning a boarding pass at an airport kiosk, users scan their electronic GO Pass once they arrive on campus. The results can be read using any smartphone or GO Pass kiosk. No specific symptom data are shared, instead venues receive anonymous, time-stamped images of the results to verify whether or not a user has been cleared for entry. GO Pass is designed to improve outcomes while overcoming the poor performance of contact tracing and isolation. It is based on immunology, science, and data analytics.

The Clio Health Go app is currently available in the App Store and Google Play and in closed pilots with area schools, health systems, medical practices, food processing plants, community and religious organizations. The app is scheduled to roll out nationally this fall. During the pilot phase, you can get access to GO Pass through a Kickstarter campaign. A variety of reward bundles are available to GO Pass backers. The campaign ends in early October.

Steve Lisk, Head of School, at Lancaster Country Day, said, “Staff and students can now complete COVID-19 screening remotely in their homes or car line prior to nearing the building or boarding the bus. This reduces the risk that someone will spread the virus on campus. GO Pass uses encryption to secure identity and medical data, providing an additional layer of privacy to those opposed to facial recognition technologies. GO Pass facilitates consistent and easy screening. It has simply taken our COVID-19 protocol to the next level.”

Mike Simpson, Head of The Stone Independent School, stated: “We pride ourselves on providing students with tools and resources that shape the 21st century. We are thrilled to provide our staff and students with a hands-on 21st century solution for COVID-19 preparedness. Our students get an opportunity to use technologies and AI-assisted insights that not only protect our community at Stone, but ultimately improve and shape the future of health and safety for all.”

“Screening employees was causing huge lines at shift changes and lots of employee frustration. The GO Pass system actually made the process ‘kind of cool’ – it’s fast and it gives our employees confidence in the safety of our workplace,” said Jeff Lehman, President, Shank’s Extracts, LLC.

GO Pass personal information is secured by Powch™, a patent-protected pseudonymity system. It protects identity using cryptography, in a manner similar to Bitcoin and blockchain. In keeping with its mission to further public good, Clio Health will open source COVID-19 risk assessment algorithms used in GO Pass, and will share anonymized data to foster advancements in battling the pandemic.

ABOUT CLIO HEALTH GO AND GO PASS

Clio Health Go is focused on leveraging AI to disrupt healthcare and change the way we manage, understand, and improve our health. It is a subsidiary of Aspire Ventures, LLC.

GO Pass is a product of MedStatix, an Aspire Ventures sister company. GO Pass is powered by Aspire’s adaptive AI platform, A2I, to provide on-demand access to automated health assessments, deeper health insights, and action plans for better health and wellness. GO Pass is the most recently developed feature on the Clio Health Go platform. https://clio.health/

Committed to innovation in healthcare, Aspire Ventures co-founded the Smart Health Innovation Lab (iLab) with Penn Medicine Lancaster General Health and Capital BlueCross in 2017, effectively bringing down the long-standing operational silos in healthcare that have made it difficult to create lasting change. The collaborative work at iLab has resulted in global recognition and continues to fuel innovation.

Contact:

Melissa Sfida-Allen

melissa@aspirevc.com

717-799-9195

Share article on social media or email:

Catalent Biologics and Humanigen to Present a Case Study on Accelerated Scale Up of a Monoclonal Antibody to Treat COVID-19 at BioProcess International Conference


Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will present at the upcoming BioProcess International virtual conference, taking place between Sept. 21 – 25, 2020.

The COVID-19 pandemic has seen innovators looking to accelerate timelines in order to bring safe and effective potential therapies to patients quickly. During the conference’s “Manufacturing Strategy & Bioprocessing 4.0” session track, on Wednesday, Sept. 23 at 3:40 p.m. EDT, Melanie Lasher, Manager, Project Management, Catalent Biologics, and Cameron Durrant, M.D., MBA, Chairman and Chief Executive Officer, Humanigen, will jointly present a case study on the investigational monoclonal antibody, lenzilumab, and its development from gene to late stage clinical trials. During their presentation, titled “Accelerating Manufacturing for Investigational COVID-19 Therapeutic Candidate Lenzilumab to Prevent and Treat Cytokine Storm”, Ms. Lasher and Dr. Durrant will discuss how Catalent Biologics and Humanigen have collaborated to address the challenge of manufacturing scale-up to bring lenzilumab to patients as quickly as possible. A Phase 3 study is currently underway evaluating hospitalized patients with COVID-19.

Ms. Lasher has more than 10 years’ experience in the biopharma industry. She has managed a variety of clinical, process and performance qualification, and commercial projects, supporting drug substance manufacturing, drug product filing, and packaging. Ms. Lasher is the program management lead for Catalent’s OneBio® Suite, an integrated solution for the development, manufacturing and supply of biologic drugs, designed to accelerate timelines, reduce risk and simplify the process for sponsor companies looking to bring their biologic to clinic and market. Ms. Lasher received a bachelor’s degree from Indiana Wesleyan University, Marion, Indiana, and is a certified Project Management Professional.

Dr. Durrant is an entrepreneur, board member, C-level executive, former big pharma executive and a medical doctor by original training. He is a prior regional winner of the Ernst and Young ‘Entrepreneur of the Year’ award, named in the PharmaVoice 2005, 2006, 2007 and 2010 list of one of the ‘100 most inspiring people in the pharmaceutical industry’. Dr. Durrant earned his medical degree from the Welsh National School of Medicine, Cardiff, U.K., and holds a Diploma of the Royal College of Obstetricians and Gynaecologists, London, U.K., as well as being a Member of the Royal College of General Practitioners, London. He also holds a DipCH from the Melbourne Academy, Australia and a Master of Business Administration from Henley Management College, Oxford, U.K.

The presentation will be available to view on-demand through the conference platform. For more information about the event, please visit https://biologics.catalent.com/events/bioprocess-international.

About Catalent Biologics

Catalent Biologics is a global leader in development, manufacturing and analytical services for new biological entities, cell and gene therapies, biosimilars, sterile injectables, and antibody-drug conjugates. With over 20 years of proven expertise, Catalent Biologics has worked with 600+ mAbs and 80+ proteins, produced 13 biopharmaceutical drugs using GPEx® cell line development technology, and manufactured 35+ commercially approved products. Catalent Cell & Gene Therapy, a unit of Catalent Biologics, is a full-service partner for adeno-associated virus (AAV) vectors, lentiviral vectors and CAR-T immunotherapies, with deep experience in viral vector scale-up and production. When Catalent acquired MaSTherCell, it added expertise in autologous and allogeneic cell therapy development and manufacturing. Catalent Cell & Gene Therapy has worked with industry-leading partners across 70+ clinical and commercial programs. For more information, visit biologics.catalent.com

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Precision Digital Dentistry recently recognized as a 2020 Top Patient Rated Bridgewater Dentist by Find Local Doctors


News Image

Precision Digital Dentistry staff members always strive to offer patients the highest level of personalized, exceptional dental care, so it is certainly an honor to be recognized as a 2020 Top Patient Rated Dentist, says Dr. Joyce Guojun Ma

Precision Digital Dentistry, located at 674 US Highway 202/206, Building 4 (Suite 7), in Bridgewater, NJ, is a modern, state-of-the-art family dental practice. This dental clinic is well-known for providing patients with beautiful, digitally designed smiles, using the latest advancements to deliver cutting-edge dentistry. Find Local Doctors is a trusted online directory that helps consumers easily locate qualified and reputable physicians and dentists. They have recognized Precision Digital Dentistry as a 2020 Top Patient Rated Bridgewater Dentist due to their substantial volume of superb patient reviews.

Dr. Joyce Guojun Ma and her skilled dental team enjoy serving residents of Bridgewater with quality, cutting-edge dental care delivered in a professional and welcoming environment. Providing comprehensive dental care for patients of all ages, this practice offers a wide range of services, including general dentistry, cosmetic dentistry, implant dentistry, orthodontics and pediatric dentistry. With dental implants, Precision Digital Dentistry utilizes revolutionary 3D technology so patients can receive them in just one visit. They also provide orthodontic services with the latest digital scanning technology for improved accuracy. At Precision Digital Dentistry, you will notice the difference from the moment you step into their Bridgewater dental office. Friendly staff members and amenities welcome you and make your comfort a top priority. This professional dental team is proud to offer patients the top-quality, affordable dental care they deserve.

“Precision Digital Dentistry staff members always strive to offer patients the highest level of personalized, exceptional dental care, so it is certainly an honor to be recognized as a 2020 Top Patient Rated Dentist,” says Dr. Joyce Guojun Ma

More about Dr. Joyce Guojun Ma:

Joyce Guojun Ma DDS, Ph.D. earned her dental degree from Beijing Medical University (Peking University) in 1998 and then a Ph.D. in neuroscience from Johns Hopkins University in 2005. In 2010, Dr. Ma attained a DDS degree from NYU College of Dentistry. Dr. Ma has trained at the world-famous Las Vegas Institution in neuromuscular dentistry. She is an AGD (Academy of General Dentistry) fellow, a graduate of Rutgers University’s Maxi Implant program, an ICOI (International Congress of Oral Implantologists) fellow and a graduate of USDI Orthodontics. During her dental career, she has received many awards and presented at numerous dental meetings and conferences. Dr. Ma has been published in several studies in peer-reviewed journals and is a member of multiple professional dental organizations.

For more information about Precision Digital Dentistry in Bridgewater or to schedule an appointment, please visit http://www.precisiondigitaldentistry.com or call (908) 955-6999.

Share article on social media or email:

Prime Dental Care recognized by Find Local Doctors as a 2020 Top Patient Rated Princeton Dentist


News Image

Being recognized by Find Local Doctors as a 2020 Top Patient Rated Dentist is such an honor. Our professional team will continue to diligently provide patients with the outstanding dental care they deserve, says Dr. Ma of Prime Dental Care.

Prime Dental Care is a comprehensive, family dental practice dedicated to delivering high-quality dental care in a professional and caring environment. Find Local Doctors is a trusted online directory that helps consumers easily locate qualified and reputable physicians and dentists in their area. Prime Dental Care joins and the elite group being recognized for the five-star reviews they have earned from multiple, reputable online sources. This well-respected dental practice serves the residents of Princeton and the surrounding areas with cutting-edge dentistry and a wide range of services, ranging from routine preventative care and general dentistry to advanced cosmetic dental treatments and complex restorative services. Dr. Joyce Guojun Ma and Dr. Nilay Patel bring diverse training and experience in the dental field and are offer specialized procedures such as dental implants, short-term orthodontics, laser dentistry and neuromuscular therapies for TMJ disorders, utilizing the latest in dental technology, such as digital imaging and the state-of-the-art Luxar C02 surgical laser. Prime Dental Care provides extended appointment hours and flexible payment options to maximize patient comfort and convenience. Whether a patient needs a routine dental cleaning or porcelain veneers, they can take advantage of luxurious modern amenities provided at this practice.

“Being recognized by Find Local Doctors as a 2020 Top Patient Rated Dentist is such an honor. Our professional team will continue to diligently provide patients with the outstanding dental care they deserve,” says Dr. Ma of Prime Dental Care.

More about Dr. Joyce Guojun Ma:

Joyce Guojun Ma DDS, Ph.D. earned her dental degree from Beijing Medical University (Peking University) and a Ph.D. in neuroscience from Johns Hopkins University. In 2010, Dr. Ma attained a DDS degree from NYU College of Dentistry. Dr. Ma has trained at the world-famous Las Vegas Institution in neuromuscular dentistry. She is an AGD (Academy of General Dentistry) fellow, a graduate of Rutgers University’s Maxi Implant program, an ICOI fellow and a graduate of USDI Orthodontics. Dr. Ma has been published in several studies in peer-reviewed journals and is a member of multiple professional dental organizations.

More about Dr. Nilay Patel:

Dr. Patel graduated from a 7 year accelerated BS/DMD program through Fairleigh Dickenson University and the University of Medicine and Dentistry of New Jersey. He received his dental degree in 2011 and has attended numerous postgraduate programs, including a maxillofacial surgery internship from UMDNJ. Dr. Patel has also served our country as a Captain in the New Jersey National Guard. He is committed to learning the latest dental technologies and procedures and is certified in Invisalign, CEREC CAD/CAM and implant placement procedures.

Prime Dental Care is located at 417 Wall Street in Princeton, NJ. For more information please visit http://www.primedentalsmiles.com or call (609) 651-8618.

Share article on social media or email:

Hartman Announces Clean Air Initiative in Texas Office Buildings to Fight Covid-19


“The health and safety of our tenants has always been and always will be our number one priority,” states Al Hartman, Chairman and CEO.

Hartman Income REIT Management (Hartman), a commercial real estate firm management based in Houston, TX, announces its Clean Air Initiative as an additional effort to help protect its tenants from Covid-19 and other air-borne viruses by installing the Needlepoint Bi-Polar Ionization system.

With more than 60 office buildings across Texas, Hartman once again demonstrates its commitments to the safety and wellbeing of its tenants with this investment. This is in combination with earlier launched initiatives such as additional cleaning protocols, social distancing measures, and awareness of CDC guidelines.

As one of the first office property owners leading the market with the installation of the GPS Bi-Polar Ionization devices, Hartman has installed the device on all ten floors of its property at 613 NW Loop 410 in San Antonio and is in the process of installation at three additional properties, 11211 Katy Freeway, 2909 Hillcroft, and 2040 North Loop West in Houston.

“The health and safety of our tenants has always been and always will be our number one priority,” states Al Hartman, Chairman and CEO. “We are constantly looking for alternative ways to improve our tenants’ experiences at our properties. This investment offers protection and peace of mind to our tenants and their patrons.”

The technology of Needlepoint Bi-Polar Ionization implements an air cleaning process that eliminates over 96% of airborne pathogens, molds, and viruses. The compact air purification device can be directly attached to an AC unit and can clean up to 3,200 CFM (cubic feet per minute.) According to HVAC & Refrigeration Insider, the process is scientifically proven to destroy 84% of Coronaviruses within 10 minutes and can destroy up to 99.4% of the Coronaviruses within 30 minutes.

Hartman’s Director of Operations for Property Management, Angel Gonzales, proudly stated, “The fact that Hartman cares so much about our tenants that we are implementing leading edge technology like the ionization system is incredible. One of the most common questions we are asked by a prospective tenant is building health and safety. So, to be able to tell them about our clean air initiative is a very compelling advantage we have over other buildings they might be considering.”

Vice-President of Leasing for San Antonio, where the first property had the devices installed, Kacie Skeen shared, “Hartman taking the proactive initiative to install Needlepoint Bipolar Ionization into the building, serves as a testament to the Company’s core value of caring for the customer. We value our tenant’s, their employees, their patrons, and our team, so it comes as no surprise that Hartman is making this investment to procure a safe working environment and is helping businesses facilitate their return to work. “

Hartman views this addition to its health and safety precautions as a value-add for both current and future tenants at the implemented properties. Hartman is proud to pioneer a clean air movement and provide its tenants with the best conditions to run their businesses and find success.

About Hartman: Hartman is a premier property management company in the Houston, Dallas and San Antonio markets. Hartman has owned and operated commercial office properties since 1983, offering premium office space at attractive rates. With more than 37 years of commercial leasing expertise in Houston, San Antonio and Dallas, Hartman knows exactly what their customers require. For more information, visit http://www.hi-reit.com.

Contact:

Malori Bizzell

Marketing Manager

Hartman Income REIT Management, Inc.

214.432.3708

mbizzell@hi-reit.com

Share article on social media or email:

The PharmEase Group Acquires RAM Pharma and Creates New Company, Compound Preferred


Compound Preferred Logo

We feel this is the right time to strategically align our business to help more organizations of all sizes overcome the challenge of managing pharmacy needs, while reducing their costs.

The PharmEase Group announces the strategic acquisition of RAM Pharma, a 503B compounding outsourcing facility. The acquisition was finalized on July 23, 2020.

RAM Pharma will be a wholly owned subsidiary of The PharmEase Group and will operate under a new name, Compound Preferred. The transaction strengthens The PharmEase Group’s market presence nationally and enhances existing relationships with providers, as well as a growing patient base. The Compound Preferred name is the result of combining the existing brands under one umbrella while reinforcing PharmEase’s core competency as a trusted leader in pharmacy.

“Having been in business for 20 years and with a deep understanding of the pharmacy industry, we feel this is the right time to strategically align our business to help more organizations of all sizes overcome the challenge of managing pharmacy needs, while reducing their costs,” said Reece Christensen, CEO of The PharmEase Group.

Compound Preferred, the new 503B outsourcing facility, complies with all cGMP standards including:

  • Processes designed to ensure that every formulation conforms to high standards for identity, strength, quality, and purity.
  • Full sterile gowning compliant with cGMP regulations.
  • Environmental monitoring of air, cleanroom surfaces and personnel.
  • Each batch of sterile product is tested prior to release: USP 71 compliant sterility testing and USP 85 compliant endotoxin.
  • Cleaning, sterilization and process validation protocols.
  • Stability programs.

“Casey Hunter, our QA Manager will ensure our standards will remain at the highest quality and purity. His dedication to these high standards comes from 10 experience in both pharma and retail pharmaceuticals,” said Christensen.

Since 2016, Rob Myers, the founder and former owner of RAM Pharma has driven the growth of RAM Pharma. He will continue with the new company, Compound Preferred, while serving as Operations Manager. “Through this strategic transaction, our combined company strength will establish a robust environment for our continued growth,” said Myers.

“RAM Pharma was a strong fit with The PharmEase Group’s strategic focus to integrate and expand its compounding outsourcing services. This acquisition drives significant operating synergies and enables us to maximize and expand our market reach nationally,” said Christensen.

About The PharmEase Group

Established in 2001, The PharmEase Group is located in Idaho Falls, Idaho and is a leader in the pharmacy industry. The PharmEase Group is comprised of multiple companies including Heartland Long Term Care Pharmacy and Compound Preferred; and employs approximately 200 staff members with locations in Idaho, Colorado and Utah. For more information, go to PharmEaseRX.com.

Share article on social media or email:

HealthJoy Releases 2021 State of the Benefits Experience Report


We hope this contribution helps our industry understand problems and innovate solutions that continue to put the employee experience first.”

Today HealthJoy, the first and only benefits experience platform, is pleased to announce the release of its 2021 State of the Benefits Experience Report. With data gleaned from a survey sent to over 9,000 HR professionals, the report contains insights into their perceptions, struggles, plans, and priorities for 2021.

HealthJoy’s first benchmarking report is released at a time of considerable uncertainty for human resources departments around the country. The survey that informed this report ran in July, while HR professionals were planning for open enrollment and mired in challenges related to the pandemic. It focused on forward-looking questions in an effort to identify problems and solutions for the 2021 plan year.

The report is available to download today, and HealthJoy CEO Justin Holland will host a webinar presenting findings and additional insights on Sept. 30.

The State of the Benefits Experience Survey uncovered that:

  • Eighty-nine percent of those surveyed reported placing more emphasis on virtual care as a result of the COVID-19 pandemic
  • HR pros surveyed spend an average of 9 hours per week answering employee benefits questions
  • Fifty-nine percent of those surveyed listed “creating better healthcare consumers” as their primary cost-containment strategy for 2021, but the same number reported they don’t offer a solution to make it easier for employees to shop for care
  • Eighty percent of companies won’t expand or reduce their benefits offerings next year

“The upcoming plan year will look like nothing we’ve seen before, and employees need more help than ever,” Holland said. “Taking the pulse of the benefits experience at this juncture reveals exactly what HR is juggling in this unusual time. We hope this contribution helps our industry understand problems and innovate solutions that continue to put the employee experience first.”

The full 2021 State of the Benefits Experience Report includes additional insights and perspectives, and is available at: https://healthjoy.com/ebooks/2021-state-benefits-experience/.

About HealthJoy

HealthJoy is a first-of-its-kind benefits experience platform helping companies save money on their healthcare while improving employee satisfaction. Through personalized guidance and AI technology, HealthJoy empowers employees to better use and understand their benefits. HealthJoy integrates with a client’s existing benefits package to deliver each employee a personalized, proactive experience. Employees gain access to on-demand medical consultations, live healthcare concierges, Rx savings, and much more. For more information, visit http://www.healthjoy.com.

Share article on social media or email:

BuyLottoNow® Cashless Lottery Mobile Payment Platform Brings Zero Percent Merchant Processing Fees to 30,000 Convenience Stores


“The BuyLottoNow solution eliminates transaction fees for the retailer which is their number one concern. In fact, it may very well be the first time a payment system isn’t charging the fee to the retailer. Plus, there’s the extra benefit of a loyalty engagement program,” said CEO Joe Randazza.

Announcing BuyLottoNow, http://www.buylottonow.com, a new cashless payment platform that allows c-stores to accept payment for draw games and scratch off tickets easily on a mobile phone with a seamless interface into existing POS terminals. Today, BuyLottoNow is bringing its proprietary decoupled debit mobile payment platform featuring no processing fees to c-store operators. In addition to no processing fees, BuyLottoNow makes lottery a potential winning loyalty program that can drive increased in-store foot traffic through merchant branded no cost email campaigns. Unlike cash, the platform knows who a retailer’s lottery players are, where and what they are buying and how much they are spending so the retailer can target such products as gas and merchandise offers to these customers.

Today online lottery sales are in their infancy with approximately $2 billion in sales. It is estimated that the 13 states currently selling lottery products online will reduce c-store retailers’ commissions by $126 million this year alone. The pandemic has caused states to accelerate their interest in online lottery sales pushing projections to $262 million in reduced commissions to retailers by 2025.

While the nation continues its rapid movement away from cash transactions, high processing fees mean convenience retailers won’t be able to accept cash for Lotto sales. On the slim margins these retailers make on debit and credit payments, they cannot afford to promote such card payments for Lotto sales because of costly processing fees.

“The BuyLottoNow solution eliminates the transaction fee for the retailer which is their number one concern. In fact, it may very well be the first time a payment system isn’t charging the fee to the retailer. Plus, the extra benefit of a loyalty engagement program makes participating retailers a VIP destination for lottery players,” says Joe Randazza, CEO of BuyLottoNow, who also co-founded National Payment Card Association that attracted millions of enrolled users to c-store branded rewards programs. “Cash is suppressive to the impulse of high jackpot games or $20 scratch off tickets. Cashless payment will bring a lift in sales and commissions,” says Randazza.

A convenience fee of $0.30 per transaction, regardless of the transaction size is charged to the consumer for the convenience of paying for lottery products with their phone. Mr. Randazza says that, “By making lottery a winning loyalty program, c-stores can retain current customers and reduce or offset the loss in in-store traffic from online sales.”

Interested parties can learn more about the merchant and consumer benefits of the BuyLottoNow payment platform from the following two videos that can be found at:

https://www.buylottonow.com/videos/Buy_Lottery_with_Your_Phone.mp4

https://www.buylottonow.com/videos/Make_Lottery_A_Winning_Loyalty_Program.mp4

For more information about BuyLottoNow and to set up an interview with a company official, please contact Shep Doniger at 561-637-5750 and sdoniger@bdcginc.com.

About iVertical Payment Network d/b/a: BuyLottoNow

(http://www.buylottonow.com) is a Fintech company with a proprietary cashless payment platform designed for the $91 billion state lottery industry utilizing the business methods of 9 issued U.S. Patents. Our platform is a seamless payment interface into a retailer’s existing POS Terminals. The company is a Gold Level Member with Conexxus, http://www.Conexxus.org, a non-profit member driven organization that helps set technology standards in the c-store and petroleum industries.

iVertical Payment Network’s management team of electronic payment professionals has worked together for 16 years providing payment solutions to Convenience Stores and has implemented the best-in-class data security for mobile payments.

Contact:

Shep Doniger

BDCG, Inc,

561-637-5750

sdoniger@bdcginc.com

Share article on social media or email:

Intouch Insight Ltd. Launches Virtual Audit Product To Ensure Regulatory Compliance


Intouch Insight logo

Intouch Insight, Customer Experience Management and Field Research Software and Services Company

Today we have a game changing way for the audit to be performed virtually including a real-time signature from the sales representative and the auditor validating the final results,” said Cameron Watt, President and CEO.

Intouch Insight Ltd. (“Intouch” or the “Company”) (TSXV: INX) (OTCQB: INXSF) today announced that it has developed a version of its audit capability that allows companies to ensure compliance with regulatory as well as certain operating standards while avoiding additional physical proximity for their employees. These virtual audit services are offered through Intouch as well as through its GCS Field Research brand which primarily handles regulatory audits including those around the Prescription Drug Marketing Act (“PDMA”).

“As it became apparent that COVID-19 was presenting long term changes to the landscape, we began to develop alternative ways we could assist our customers who were the most affected. Being able to enhance our technical offering to perform virtual audits became top priority. We determined what functionality needed to be developed as well as what tools were currently available and created a plan to support our partners with their critical audit needs in a safe and remote fashion,” said Cameron Watt, President and CEO.

“The best example of an application for our new capabilities is in performing PDMA audits. These audits allow pharmaceutical companies to adhere to regulatory requirements and are often performed in the homes of sales representatives. With social distancing and household bubbles becoming the norm we had to bring an alternative to achieve these audits without physical interaction while still adhering to the strict guidelines of these important audit activities. Today we have a game changing way for the audit to be performed virtually including a real-time signature from the sales representative and the auditor validating the final results,” said Watt.

“I am pleased to share that the product was swiftly adopted by customers including the transition of a current program with a fortune 100 North American pharmaceutical company. We remain committed to continued innovation as we navigate the ever changing landscape and look forward to making our virtual offerings broadly available,” said Watt.

About Intouch Insight

Intouch Insight (TSXV: INX) (OTCQB: INXSF) offers a complete portfolio of customer experience management (CEM) products and services that help global brands delight their customers, strengthen brand reputation and improve financial performance. Through its flagship SaaS product, LiaCXTM, Intouch helps clients collect and centralize data from multiple customer touch points, gives them actionable, real-time insights, and provides them with the tools to continuously improve customer experience. Founded in 1992, Intouch is trusted by over 300 of North America’s most-loved brands for their customer experience management, survey, mystery shopping, mobile forms, operational and compliance audits, and event marketing automation solutions. For more information, visit intouchinsight.com.

Certain statements included in this news release, including those relating to the Company’s proposed transaction, future revenues and expansion, contain forward-looking statements, which by their nature are necessarily subject to risks and uncertainties and other factors that may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such statements reflect the Company’s current views with respect to expectations, estimates, future events, and are based on information currently available to the Company and on hypotheses which it considers to be reasonable; however, management warns the reader that hypotheses relative to future events which are beyond the control of management could prove to be false, given that they are subject to certain risks and uncertainties. The Company does not undertake any obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this presentation or to reflect the occurrence of unanticipated events, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

Share article on social media or email:

Brand New Day Taps New Care Partner In Hills Physicians Medical Group


BRAND NEW DAY TAPS NEW CARE PARTNER IN HILL PHYSICIANS MEDICAL GROUP

(Medicare Advantage Plan Joins Forces With No Cal Physicians Group To Expand Coverage Throughout State)

 

Brand New Day, a Medicare Advantage Prescription Drug Plan headquartered in Westminster, CA, has contracted with a new care partner, Hill’s Physicians Group, the largest network of independent doctors in Northern California.  Hill Physicians doctors will be made available to new and existing members beginning January 1, 2021 in San Francisco, San Mateo, Sacramento and San Joaquin counties.   

 

Brand New Day’s Executive Vice President Jay B. Davis says that the addition of Hill Physicians Medical Group will help the company expand its reach into new, untapped markets. Furthermore, the combined membership will allow members to benefit from a greater pool of resources. 

 

“We’re delighted to announce our new care partner, the prestigious and widely respected Hill Physicians Medical Group and its distinguished roster of care providers.  Together, we look forward to expanding our outreach and serving a wider range of members including those eligible for Medicare and Medicare and Medi-Cal,” said Davis.   

 

Added David Joyner, CEO of Hill Physicians Medical Group, “We are pleased to expand our Medicare Advantage footprint with Brand New Day. This new plan will offer Medicare Advantage members access to care through a large network of physicians they trust.”

 

Brand New Day members may select a Hill’s Physicians Group care provider effective immediately.  Those interested in enrolling in Brand New Day may do so during the upcoming Annual Election Period to be held October 15 – December, 7 2020 with a start date of January 1, 2021.  

About Hill Physicians Medical Group

Hill Physicians Medical Group is the largest independent physician association in Northern California. Since 1984, it has provided consumers access to quality, patient-focused healthcare. The group, comprised of more than 4,000 primary care and specialty physicians, partners with leading health plans and hospitals, giving members access to healthcare in 11 counties spanning the Sacramento, San Joaquin and San Francisco Bay areas. Comprehensive case management programs, targeted clinical initiatives and a dedication to technological advancement place it at the forefront of the industry. Hill Physicians is consistently acknowledged as one of the top-performing medical groups in the state by The Integrated Healthcare Association and Association of Physician Groups. For more information, visit: http://www.HillPhysicians.com.

 

About Brand New Day

Brand New Day, a Medicare Advantage prescription health plan available in 12 California counties, offers a number of specialty plans in addition to its standard Medicare plan.  They include the Embrace Plan for members with heart disease, hypertension and/or diabetes; Bridges Plan for members with dementia and Alzheimer’s; SelectCare Plan for members residing in long-term care (nursing homes) facilities; and Harmony Plan for members with mental illness including major depression, schizophrenia, schizoaffective disorder, bipolar disorder and paranoid disorder.

 

For qualifying members, the plans cover transportation to and from medical appointments; vision, dental and hearing aids; 24-hour/day nurse and physician line; and health nurses and life coaches.  In addition, members with chronic illnesses are not only treated medically, but in a variety of other ways including education about the member’s chronic or ongoing medical conditions and avoidable risks, nutrition, exercise, self-testing and monitoring, medication adherence to doctor orders, preventive care planning and linkage to community support programs.

 

Brand New Day offers comprehensive benefit programs designed for its members’ unique healthcare needs. In addition to its Medicare only, Medicare and Medi-Cal members, the plan offers specialized programs for those with ongoing medical conditions including Diabetes, Cardiovascular Disease, Dementia and Mental Illness.  It also serves those who live in long-term care facilities. Brand New Day’s personalized approach is designed to keep its members healthy and independent and its team of caring healthcare professionals share one common goal — to improve the overall well-being of each member by offering members “healthcare you can feel good about.”

 

For more information about Brand New Day, visit BNDHMO.com or call (866) 255-4795.

CONTACT: FGI (562) 225-9981

Share article on social media or email: